Antibiotic prescribing for children. Too much and too little? Retrospective observational study in primary care

Suzie Ekins-Daukes1, James S McLay, Michael W Taylor

  • 1Department of Medicine and Clinical Pharmacology, The University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen AB25 2ZD, UK.

Insights

Off-label antibiotic prescribing in children, particularly lower doses, is common in primary care. This practice, often due to not adjusting doses for age, may increase antibiotic use and resistance risks.

Area of Science:

  • Pediatric pharmacology
  • Antimicrobial stewardship
  • Primary care medicine

Background:

  • Antibiotic prescribing in children is a significant public health concern.
  • Off-label prescribing, including incorrect dosing, is prevalent in pediatric primary care.
  • Understanding dose-related prescribing patterns is crucial for optimizing antibiotic use.

Purpose of the Study:

  • To investigate the prevalence of dose-related off-label antibiotic prescribing in children within primary care.
  • To identify clinical effects associated with off-label antibiotic dosing in pediatric patients.
  • To specifically examine the impact of lower-than-recommended antibiotic doses.

Main Methods:

  • Retrospective analysis of antibiotic prescriptions for 168,396 children (aged 0-16 years) in Scottish general practices (1999-2000).
  • Data extracted from the national Scottish primary care computer system (GPASS).
  • Comparison of prescribed doses against Summary of Product Characteristics (SPC) recommendations.

Main Results:

  • 14.2% of children received at least one antibiotic course; 19.2% were prescribed doses below SPC recommendations.
  • Lower-than-recommended doses were more frequent in older children (12-16 years) and at ages where SPCs recommend dose increases.
  • Prescribing sub-therapeutic doses was not linked to increased short-term re-prescription but was associated with a 48% rise in total annual antibiotic courses for 5-11 year olds.

Conclusions:

  • Off-label antibiotic prescribing at sub-therapeutic doses is common in pediatric primary care.
  • This prescribing pattern often results from failing to escalate antibiotic doses according to age-based SPC guidelines.
  • Standardizing age-based dosing increments could reduce off-label prescribing and mitigate antibiotic resistance development.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...